2017 Clinical trials update: Innovations in hemophilia therapy.

2017 Clinical trials update: Innovations in hemophilia therapy.

Item
http://www.wikidata.org/entity/Q38937725
ASH Meeting 2016: developments in hemostaseology.Predicting dose sparing benefit and bleeding risk of pharmacokinetic-based personalized prophylactic dosing of factor VIII products.Genome engineering: a new approach to gene therapy for neuromuscular disorders.Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma.Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions.Targeting anticoagulant protein S to improve hemostasis in hemophilia.Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice.The impact of extended half-life versus conventional factor product on hemophilia caregiver burden.Gene Therapy for Hemophilia.Gene therapy in hemophilia A: a cost-effectiveness analysisAn Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs
P2860

2017 Clinical trials update: Innovations in hemophilia therapy.

Item
http://www.wikidata.org/entity/Q38937725
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
2017 Clinical trials update: Innovations in hemophilia therapy.
@en
type
label
2017 Clinical trials update: Innovations in hemophilia therapy.
@en
prefLabel
2017 Clinical trials update: Innovations in hemophilia therapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
2017 Clinical trials update: Innovations in hemophilia therapy.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921